Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 638.0K sh | Mar 20, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 9,167 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 32.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 18.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Smith Robert Paul JRChief Commercial Officer | Grant or award | A | — 572.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 18.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Plaines StephanieDirector | Grant or award | A | — 7,142 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 100.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 562.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | dMY Squared Sponsor, LLCDirector, 10% Owner | Derivative conversion | C | — 1.16M sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 60.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Nixon D. GailSenior VP, Human Resources | Option exercise | M | — 123.5K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 162.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 9,167 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 125.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 126.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 487.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 181.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 211.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Wininger ShaiDirector, President | Grant or award | A | — 180.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 40.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 693.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Marcus Andrew T.See Remarks | Grant or award | A | — 14.6K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 506.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 506.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 440.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 30.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 126.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Gessert EricaChief Financial Officer | Option exercise | M | — 8,433 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 60.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 47.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Brown HaydenDirector, President & CEO | Option exercise | M | — 28.7K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aulestia Bernadette S.Director | Grant or award | A | — 905 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 543.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Keough KelliEVP, GBUL, SIPS | Open-market sale · 10b5-1 plan | SELL | $165K 9,742 sh | Mar 20, 2026 traded Mar 20, 2026 |
| 9 | Statham JamiSVP, General Counsel | Tax withholding | F | $5,406 4,395 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Smith Robert Paul JRChief Commercial Officer | Disposition to issuer | D | — 562.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 22.8K sh | Mar 20, 2026 traded Mar 19, 2026 |